Miyake S
Acta Med Okayama. 1979 Oct;33(5):343-58.
The activities of glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT) and glutamate dehydrogenase (GLD) were determined in liver biopsy specimens and sera of patients with various liver diseases. Mitochondrial and cytosol isozymes of GOT were also separated for their assay. The activity ratio of GOT/GPT in serum was found to reflect the ratio in liver cytosol. The increased ratio in advanced or severe liver diseases, such as liver cirrhosis, was due to the greater decrease in liver cytosol GPT activity, this being pronounced in primary hepatoma. The activity of GLD decreased similarly but less markedly. The relatively greater decrease in GPT compared with GOT in advanced liver diseases was not mainly due to leakage of the enzyme from the liver, but to a specific mechanism associated with hepatic injury or its progression. Other pathological conditions of the liver such as those in obstructive jaundice and alcoholic liver injury also appeared to result in reduced liver GPT activity, which was reflected in the serum as an increased GOT/GPT ratio.
对各种肝脏疾病患者的肝活检标本和血清中的谷草转氨酶(GOT)、谷丙转氨酶(GPT)及谷氨酸脱氢酶(GLD)活性进行了测定。还对GOT的线粒体同工酶和胞浆同工酶进行了分离测定。发现血清中GOT/GPT的活性比值反映了肝细胞浆中的比值。在肝硬化等晚期或严重肝脏疾病中该比值升高,是由于肝细胞浆中GPT活性下降幅度更大,这在原发性肝癌中尤为明显。GLD的活性也有类似下降,但程度较轻。在晚期肝脏疾病中,与GOT相比GPT下降相对更明显,这主要不是由于酶从肝脏泄漏,而是与肝损伤或其进展相关的一种特殊机制。肝脏的其他病理状况,如梗阻性黄疸和酒精性肝损伤,似乎也导致肝脏GPT活性降低,这在血清中表现为GOT/GPT比值升高。